Journal of Neuro-Oncology

, Volume 111, Issue 3, pp 337–345

Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groups

  • Martin Benesch
  • André O. von Bueren
  • Tobias Dantonello
  • Katja von Hoff
  • Torsten Pietsch
  • Ivo Leuschner
  • Alexander Claviez
  • Uta Bierbach
  • Gabriele Kropshofer
  • Rudolf Korinthenberg
  • Norbert Graf
  • Meinolf Suttorp
  • Rolf Dieter Kortmann
  • Carsten Friedrich
  • Nicolas von der Weid
  • Peter Kaatsch
  • Thomas Klingebiel
  • Ewa Koscielniak
  • Stefan Rutkowski
Clinical Study

Abstract

Purely intracranial soft tissue sarcomas (ISTS) are very rare among children. A retrospective database analysis of the Cooperative Weichteilsarkom Studiengruppe (CWS) and brain tumor (HIT) registries was conducted to describe treatment and long-term outcome of children and adolescents with ISTS. Nineteen patients from Germany, Austria and Switzerland were reported between 1988 and 2009. Median age at diagnosis was 9.7 years (range, 0.5–17.8). Central pathological review was performed in 17 patients. Eleven patients underwent a total and five a subtotal tumor resection. A biopsy was done in one patient. In two patients no data concerning extent of initial resection was available. Radiotherapy was performed in 15 patients (first-line, n = 11; following progression, n = 4). All but one patient received chemotherapy (first-line, n = 7, following progression, n = 5; first-line and following progression, n = 6). With a median follow-up of 5.8 years (range, 0.6–19.8) ten patients were alive in either first or second complete remission. Seven patients died due to relapse or progression and two were alive with progressive disease. Estimated progression-free and overall survival at 5 years were 47 % (±12 %) and 74 % (±10 %), respectively. About 50 % of patients with ISTS remain relapse-free after 5 years. Multimodality treatment including complete tumor resection and radio-/chemotherapy is required to achieve sustained tumor control in patients with ISTS. Early initiation of postoperative non-surgical treatment seems to be important to prevent recurrence. Due to the intracranial localization local therapy should follow the recommendations used in brain tumors rather than in soft tissue sarcomas, whereas chemotherapy should be guided by histological subtype.

Keywords

Soft tissue sarcomas Children Adolescents Intracranial Chemotherapy Radiotherapy 

References

  1. 1.
    Weihkopf T, Blettner M, Dantonello T, Jung I, Klingebiel T, Koscielniak E, Lückel M, Spix C, Kaatsch P (2008) Incidence and time trends of soft tissue sarcomas in German children 1985–2004—a report from the population-based German Childhood Cancer Registry. Eur J Cancer 44:432–440PubMedCrossRefGoogle Scholar
  2. 2.
    Meyer WH, Spunt SL (2004) Soft tissue sarcoma of childhood. Cancer Treat Rev 30:269–280PubMedCrossRefGoogle Scholar
  3. 3.
    Paulus W, Slowik F, Jellinger K (1991) Primary intracranial sarcomas: histopathological features of 19 cases. Histopathology 18:395–402PubMedCrossRefGoogle Scholar
  4. 4.
    Ellams ID, Hildebrandt G, Vuia O, Kaufmann U (1985) Intracranial sarcoma in childhood. Childs Nerv Syst 1:169–171PubMedCrossRefGoogle Scholar
  5. 5.
    Ironside JW (1991) Classification of primary intracranial sarcomas and other central nervous system neoplasms. Histopathology 18:483–486PubMedCrossRefGoogle Scholar
  6. 6.
    Mena H, Garcia JH (1978) Primary brain sarcomas: light and electron microscopic features. Cancer 42:1298–1307PubMedCrossRefGoogle Scholar
  7. 7.
    Al-Gahtany M, Shroff M, Bouffet E, Dirks P, Drake J, Humphreys R, Laperriere N, Hawkins C, Rutka J (2003) Primary central nervous system sarcomas in children: clinical, radiological, and pathological features. Childs Nerv Syst 19:808–817PubMedCrossRefGoogle Scholar
  8. 8.
    Tomita T, Gonzalez-Crussi F (1984) Intracranial primary nonlymphomatous sarcomas in children: experience with eight cases and review of the literature. Neurosurgery 14:529–540PubMedCrossRefGoogle Scholar
  9. 9.
    Olson JJ, Menezes AH, Godersky JC, Lobosky JM, Hart M (1985) Primary intracranial rhabdomyosarcoma. Neurosurgery 17:25–34PubMedCrossRefGoogle Scholar
  10. 10.
    Eckhardt BP, Brandner S, Zollikofer CL, Wentz KU (2004) Primary cerebral leiomyosarcoma in a child. Pediatr Radiol 34:495–498PubMedCrossRefGoogle Scholar
  11. 11.
    Scheithauer BW, Rubinstein LJ (1978) Meningeal mesenchymal chondrosarcoma: report of 8 cases with review of the literature. Cancer 42:2744–2752PubMedCrossRefGoogle Scholar
  12. 12.
    Rushing EJ, Armonda RA, Ansari Q, Mena H (1996) Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system. Cancer 77:1884–1891PubMedCrossRefGoogle Scholar
  13. 13.
    Bisogno G, Roganovic J, Carli M, Scarzello G, Calderone M, Faggin R, Perilongo G (2002) Primary intracranial fibrosarcoma. Childs Nerv Syst 18:648–651PubMedCrossRefGoogle Scholar
  14. 14.
    Gerszten PC, Pollack IF, Hamilton RL (1998) Primary parafalcine chondrosarcoma in a child. Acta Neuropathol 95:111–114PubMedCrossRefGoogle Scholar
  15. 15.
    Sardi I, Massimino M, Genitori L, Buccoliero AM, Giangaspero F, Ferrari A (2011) Intracranial mesenchymal chondrosarcoma: report of two pediatric cases. Pediatr Blood Cancer 56:685–686PubMedCrossRefGoogle Scholar
  16. 16.
    Guilcher GM, Hendson G, Goddard K, Steinbok P, Bond M (2008) Successful treatment of a child with a primary intracranial rhabdomyosarcoma with chemotherapy and radiation therapy. J Neurooncol 86:79–82PubMedCrossRefGoogle Scholar
  17. 17.
    Dantonello TM, Int-Veen C, Harms D, Leuschner I, Schmidt BF, Herbst M, Juergens H, Scheel-Walter HG, Bielack SS, Klingebiel T, Dickerhoff R, Kirsch S, Brecht I, Schmelzle R, Greulich M, Gadner H, Greiner J, Marky I, Treuner J, Koscielniak E (2009) Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol 27:1446–1455PubMedCrossRefGoogle Scholar
  18. 18.
    Koscielniak E, Harms D, Henze G, Jürgens H, Gadner H, Herbst M, Klingebiel T, Schmidt BF, Morgan M, Knietig R, Treuner J (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706–3719PubMedGoogle Scholar
  19. 19.
    Koscielniak E, Jürgens H, Winkler K, Bürger D, Herbst M, Keim M, Bernhard G, Treuner J (1992) Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study. Cancer 70:2557–2567PubMedCrossRefGoogle Scholar
  20. 20.
    von Hoff K, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD, Kuehl J, Rutkowski S (2009) Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT’91. Eur J Cancer 45:1209–1217CrossRefGoogle Scholar
  21. 21.
    von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, Zwiener I, Faldum A, Fleischhack G, Benesch M, Krauss J, Kuehl J, Kortmann RD, Rutkowski S (2011) Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol 13:669–679CrossRefGoogle Scholar
  22. 22.
    Wolff JE, Driever PH, Erdlenbruch B, Kortmann RD, Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A, Kramm CM (2010) Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer 116:705–712PubMedCrossRefGoogle Scholar
  23. 23.
    Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978–986PubMedCrossRefGoogle Scholar
  24. 24.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) World Health Organization Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer (IARC), LyonGoogle Scholar
  25. 25.
    Fletcher CDM, Unni KK, Mertens F (2002) World Health Organization of Tumors. Pathology and genetics of tumours of soft tissue and bone. International Agency for Research on Cancer (IARC) Press, LyonGoogle Scholar
  26. 26.
    Romeo S, Dei Tos AP (2011) Clinical application of molecular pathology in sarcomas. Curr Opin Oncol 23:379–384PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Martin Benesch
    • 1
  • André O. von Bueren
    • 2
  • Tobias Dantonello
    • 3
  • Katja von Hoff
    • 2
  • Torsten Pietsch
    • 4
  • Ivo Leuschner
    • 5
  • Alexander Claviez
    • 6
  • Uta Bierbach
    • 7
  • Gabriele Kropshofer
    • 8
  • Rudolf Korinthenberg
    • 9
  • Norbert Graf
    • 10
  • Meinolf Suttorp
    • 11
  • Rolf Dieter Kortmann
    • 12
  • Carsten Friedrich
    • 2
  • Nicolas von der Weid
    • 13
  • Peter Kaatsch
    • 14
  • Thomas Klingebiel
    • 15
  • Ewa Koscielniak
    • 3
  • Stefan Rutkowski
    • 2
  1. 1.Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent MedicineMedical University of GrazGrazAustria
  2. 2.Department of Pediatric Hematology and OncologyUniversity Medical Center Hamburg-EppendorfHamburgGermany
  3. 3.Pediatrics 5 (Oncology)Olgahospital, Klinikum StuttgartStuttgartGermany
  4. 4.Institute of NeuropathologyUniversity of BonnBonnGermany
  5. 5.Kiel Pediatric Tumor Registry, Department of Pediatric PathologyUniversity of Schleswig–HolsteinKielGermany
  6. 6.Department of General PediatricsUniversity of Schleswig–HolsteinKielGermany
  7. 7.Department of PediatricsUniversity Hospital LeipzigLeipzigGermany
  8. 8.Department of Pediatrics IMedical University of InnsbruckInnsbruckAustria
  9. 9.Department of Pediatric Neurology and Muscle DisordersUniversity Hospital FreiburgFreiburgGermany
  10. 10.Department of Pediatric Hematology and OncologySaarland UniversityHomburg/SaarGermany
  11. 11.University Children’s Hospital DresdenDresdenGermany
  12. 12.Department of Radiation OncologyUniversity of LeipzigLeipzigGermany
  13. 13.Pediatric Hematology-Oncology UnitUniversity Hospital CHUVLausanneSwitzerland
  14. 14.German Childhood Cancer RegistryMainzGermany
  15. 15.Division of Pediatric Hematology and Oncology, Department of PediatricsJ. W. Goethe University Children’s Hospital of FrankfurtFrankfurtGermany

Personalised recommendations